[Lymphotropic chemotherapy of patients with tuberculosis of the lymph nodes, skin and abdominal organs].
Experience gained as a result of indirect endolymphatic chemotherapy of patients with tuberculosis of the skin, peripheral and mesenteric lymph nodes is presented. The above treatment is tolerated well by the patients and causes no local or general complications. The clinical effect is achieved 1-3 months earlier than with a traditional therapy which provides a significant drop in the inpatient period and the drug load. Incidence of exacerbations also becomes less. It is worthwhile to include lymphotropic chemotherapy into a complex of therapeutic measures both at the beginning of the treatment and in a torpid course of the disease.
Dzhugostran
V Ia
VIa
Grumeza
V S
VS
Ivanov
V S
VS
Kuku
G S
GS
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage*; D003092:Colitis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007272:Injections, Intralymphatic; D008640:Mesenteric Lymphadenitis / Q000188:drug therapy*; D008875:Middle Aged; D014382:Tuberculosis, Cutaneous / Q000188:drug therapy*; D014385:Tuberculosis, Gastrointestinal / Q000188:drug therapy*; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy*
D000995:Antitubercular Agents
Limfotropnaia khimioterapiia bol'nykh tuberkulezom limfaticheskikh uzlov, kozhi, organov briushnoĭ polosti.